Missed News: Rummy’s Tamiflu Profits

Anyone will tell you, ‘Republicans are good for business.’ Especially for their own, it seems. I’ve already suggested the main campaign slogan for 2006 should be:

Republicans Mean Business

But I’m starting to appreciate Newt Gingrich’s own suggestion:

Had enough?

mjh

PS: Ask someone in the MSM how this could not be news in the US?

Independent Online Edition > Americas
Donald Rumsfeld makes $5m killing on bird flu drug
By Geoffrey Lean and Jonathan Owen
Published: 12 March 2006

Donald Rumsfeld has made a killing out of bird flu. The US Defence Secretary has made more than $5m (£2.9m) in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu, the drug being bought in massive amounts by Governments to treat a possible human pandemic of the disease.

More than 60 countries have so far ordered large stocks of the antiviral medication – the only oral medicine believed to be effective against the deadly H5N1 strain of the disease – to try to protect their people. The United Nations estimates that a pandemic could kill 150 million people worldwide.

Daily Times – Site Edition
Donald Rumsfeld makes $5m from bird flu drug

Tamiflu does not cure the disease, but if taken soon after symptoms appear it can reduce its severity. The drug was developed by a Californian biotech company, Gilead Sciences. It is now made and sold by the giant chemical company Roche, which pays it a royalty on every tablet sold, currently about a fifth of its price.

Rumsfeld was on the board of Gilead from 1988 to 2001, and was its chairman from 1997. He then left to join the Bush administration, but retained a huge shareholding.

The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year. During this time the share price trebled.

Rumsfeld sold some of his Gilead shares in 2004 reaping – according to the financial disclosure report he is required to make each year – capital gains of more than $5m. The report showed that he still had up to $25m-worth of shares at the end of 2004, and at least one analyst believes his stake has grown well beyond that figure, as the share price has soared. Further details are not likely to become known, however, until Rumsfeld makes his next disclosure in May.

Rumsfeld Gilead – Google News (at this writing, only 6 news articles — these are the only 2 about this investment — none in the US)

Gilead — Donald H. Rumsfeld Named Chairman of Gilead Sciences
Foster City, CA, January 3, 1997

Share this…